Safety Analyses Of Nrg Br004: A Randomized, Double-Blind, Phase Iii Trial Of Taxane/Trastuzumab/Pertuzumab With Atezolizumab Or Placebo In First-Line Her2-Positive Metastatic Breast Cancer (Mbc)
Atezolizumab;Pertuzumab;Trastuzumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Safety Analyses Of Nrg Br004: A Randomized, Double-Blind, Phase Iii Trial Of Taxane/Trastuzumab/Pertuzumab With Atezolizumab Or Placebo In First-Line Her2-Positive Metastatic Breast Cancer (Mbc) ### Output: Atezolizumab;Pertuzumab;Trastuzumab